These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12124950)

  • 1. Hope springs eternal: the unfulfilled promise of femoropopliteal stenting.
    Rocha-Singh K
    Catheter Cardiovasc Interv; 2002 Aug; 56(4):450-1. PubMed ID: 12124950
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease.
    Davies MG; Waldman DL; Pearson TA
    J Am Coll Surg; 2005 Aug; 201(2):275-96. PubMed ID: 16038827
    [No Abstract]   [Full Text] [Related]  

  • 3. Stenting in the femoropopliteal arterial segment.
    Mewissen MW
    Tech Vasc Interv Radiol; 2005 Dec; 8(4):146-9. PubMed ID: 16849093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppurative bacterial endarteritis after percutaneous transluminal angioplasty, stenting and thrombolysis for femoropopliteal arterial occlusive disease.
    Giannoukas DD; Tsetis DK; Touloupakis E; Alamanos E; Karniadakis S; Korakas P; Katsamouris AN
    Eur J Vasc Endovasc Surg; 1999 Nov; 18(5):455-7. PubMed ID: 10610837
    [No Abstract]   [Full Text] [Related]  

  • 5. Femoropopliteal artery obstructions: from the balloon to the stent-graft.
    Lammer J
    Cardiovasc Intervent Radiol; 2001; 24(2):73-83. PubMed ID: 11443390
    [No Abstract]   [Full Text] [Related]  

  • 6. Why endovascular therapy should be utilized before surgical bypass for femoropopliteal occlusive disease.
    Ansel GM; Botti CF; Silver Barry S George MJ; George BS
    J Invasive Cardiol; 2001 Aug; 13(8):608-10. PubMed ID: 11481513
    [No Abstract]   [Full Text] [Related]  

  • 7. Stent placement in femoropopliteal arteries.
    Clark TW
    Radiology; 2002 Jul; 224(1):297; author reply 297. PubMed ID: 12091701
    [No Abstract]   [Full Text] [Related]  

  • 8. Percutaneous viabahn-assisted subintimal recanalization (VASIR) for severe femoropopliteal occlusive disease.
    Verta MJ; Schneider JR; Alonzo M; Hahn D
    Acta Chir Belg; 2007; 107(2):181-6. PubMed ID: 17515268
    [No Abstract]   [Full Text] [Related]  

  • 9. The pitfalls of femoropopliteal stenting trials.
    Mwipatayi BP; Leong BD; Hockley J; Vijayan V
    J Endovasc Ther; 2012 Oct; 19(5):596-8. PubMed ID: 23046323
    [No Abstract]   [Full Text] [Related]  

  • 10. Focal stenting versus "metal jacket" for long subintimal recanalization of the femoropopliteal artery.
    Niazi K
    JACC Cardiovasc Interv; 2015 Mar; 8(3):481-482. PubMed ID: 25703880
    [No Abstract]   [Full Text] [Related]  

  • 11. Femoropopliteal occlusive disease: diagnosis, indications for treatment, and results of interventional therapy.
    Silver MJ; Ansel GM
    Catheter Cardiovasc Interv; 2002 Aug; 56(4):555-61. PubMed ID: 12124973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous vascular interventions in the superficial femoral artery. A review.
    Wiesinger B; Heller S; Schmehl J; Claussen CD; Wiskirchen J; Tepe G
    Minerva Cardioangiol; 2006 Feb; 54(1):83-93. PubMed ID: 16467744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal artery disease: a metaanalysis of randomized trials.
    E Y; He N; Wang Y; Fan H
    J Vasc Interv Radiol; 2008 Apr; 19(4):499-503. PubMed ID: 18375292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase II study of external-beam radiotherapy and endovascular brachytherapy with PTA and stenting for femoropopliteal artery restenosis.
    Narayan K; Denton M; Das R; Bernshaw D; Rolfo A; van Dyk S; Mirakian A
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):238-43. PubMed ID: 16820271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular treatment of femoro-popliteal obstructive disease.
    Rigatelli G; Cardaioli P; Giordan M
    Minerva Cardioangiol; 2007 Feb; 55(1):125-32. PubMed ID: 17287687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in endovascular treatment of femoropopliteal arterial occlusive disease.
    Klonaris C; Katsargyris A; Giannopoulos A; Bastounis E
    Perspect Vasc Surg Endovasc Ther; 2006 Dec; 18(4):329-41. PubMed ID: 17351203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular interventions in iliac and infrainguinal occlusive artery disease.
    Ruef J; Hofmann M; Haase J
    J Interv Cardiol; 2004 Dec; 17(6):427-35. PubMed ID: 15546296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal therapeutic approaches to femoropopliteal artery intervention.
    Das T
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):21-30. PubMed ID: 15343563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The battle of intimal hyperplasia in the war against femoropopliteal disease.
    Mauro MA
    Radiology; 2004 May; 231(2):299-301. PubMed ID: 15128980
    [No Abstract]   [Full Text] [Related]  

  • 20. Current trends in lower extremity revascularization.
    Perera GB; Lyden SP
    Surg Clin North Am; 2007 Oct; 87(5):1135-47, x. PubMed ID: 17936479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.